• Direct to consumer advertising in pharmaceutical markets 

      Brekke, Kurt Richard; Kuhn, Michael (Working paper, Working paper, 2005-02)
      We study effects of direct-to-consumer advertising (DTCA) in the prescription drug market. There are two pharmaceutical firms providing horizontally differentiated (branded) drugs. Patients differ in their susceptability ...
    • International trade with competitiveness effects in R&D 

      Pires, Armando José Garcia (Working Paper, Working paper, 2005-12)
      In an oligopoly trade model where firms engage in R&D, international differences in market size allow for the emergence of endogenous asymmetries between firms. Concretely, firms located in countries with more demand become ...
    • R&D and strategic industrial location in international oligopolies 

      Pires, Armando José Garcia (Working Paper, Working paper, 2005-12)
      In a spatial economy where Oligopolist firms compete in R&D, it is found that geography affects the innovative behaviour of firms. Notably, international differences in market size conduce to endogenous asymmetries between ...
    • Temporary bottlenecks, hydropower and acquisitions in networks 

      Skaar, Jostein; Sørgard, Lars (Working paper, Working paper, 2003-01)
      The purpose of this article is to study the effects of an acquisition in an energy system dominated by hydropower and with temporary bottlenecks. We apply a model with four markets: two regions and two time periods. It is ...
    • Two-part pricing, consumer heterogeneity and cournot competition 

      Jensen, Sissel; Sørgard, Lars (Working paper, Working paper, 2005-04)
      We analyze two-part tariffs in an oligopoly, where each firm commits to a quantity and a fixed fee prior to the determination of unit prices. In the case of homogeneous consumers, Harrison and Kline (2001) showed that the ...